|
|
||||||||
Clinical Chemistry, Vol 15, 1056-1061, Copyright © 1969 by the American Association for Clinical Chemistry
1 BMC Laboratories, 219 E 44 St, New York, NY 10017.
Preparations of reduced NAD are known to be prone to contain a substance which inhibits the catalytic activity of LDH. (1-Lactate: NAD oxidoreductase, EC 1.1.1.27).
Accepted on March 13, 1969
The following articles in journals at HighWire Press have cited this article:
![]() |
A. Kaplan, E. Weiss, S. Byrne, N. El-Torkey, and S. Margolis Purified reduced nicotinamide adenine dinucleotide: responses to lactate dehydrogenase isozymes from three cell sources Science, May 1, 1981; 212(4494): 553 - 555. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |